In an effort to create a massive awareness on the importance of stem cell banking, CordLife Sciences (India) Pvt. Ltd. is a subsidiary of CordLife Limited, which is Asia’s largest stem cell banking network, CordLife today announced Shilpa Shetty as its new brand ambassador.
As a would be mom, Shilpa Shetty not only wants to store her baby’s stem cells with CordLife but also would be actively involved in creating awareness among the would be parents on the importance of stem cell banking. She decided to bank the stems cells of her baby with CordLife, it offered the latest technology available in stem cell processing and cryopreservation in this part of the world, said Meghnath Roy Chowdhury, MD, CordLife.
With tremendous potential in curing critical diseases, stem cell therapy is the future of medical science. Stem cells extracted from the cord blood have positively treated conditions like leukaemia, lymphoma, cerebral palsy and thalassemia major. The technology is also being used to treat various other diseases as well. “CordLife is encouraged by Shetty’s decision “One Chance, One Choice” and have chosen CordLife to bank would further strengthen its efforts to serve the community in fighting life threatening diseases,” he added.
CordLife besides having branches all over India, is widely acknowledged in Asia covering Singapore, Hong Kong, Macau, Indonesia, and the Philippines over the last ten years. It is also the only stem cell bank providing a quality guarantee of US$ 30,000 to ensure the quality of cord blood stored. Under this programme, families are assured of a viable cord blood unit throughout their contractual agreement with CordLife.
In India, the company obtained its operating license in 2008 from Central and State drug regulatory authorities, It has a storage capacity of up to 1,50,000 stem cell units derived from newborns’ umbilical cord and cord blood. The ISO 9001:2008 certified 25,000 sq.ft. facility adheres to the latest international standards and CordLife group quality assurance policies.